bendroflumethiazide 2021-07-06T17:28:01Z A condition in which the main influencing factor is bendroflumethiazide, a sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. Aprinox BTZ PMID:18480177 XCO:0000862 bendrofluazide experimental_condition_ontology slaulede antihypertensive agent